DM-Density personalized breast density reporting software will be offered via vendor neutral artificial intelligence distribution platform
Appili Therapeutics Inc. (the “Company” or “Appili”), an anti-infective drug development company, is pleased to announce the appointment of Ian C. Mortimer to its board of directors.
Advanced breast imaging analytics provider, Densitas, is deploying its breast density software at clinics and hospitals throughout Canada. The software, DM-Density, helps radiologists provide high-quality personalized follow-up care to women.
Four high potential Nova Scotia medical technology companies have been selected to participate in the inaugural cohort of Innovacorp’s MedTech Accelerate Program.
A marine technology company in Halifax is receiving $40,000 to further develop its SEA-Stab mooring connector for challenging environments.
The company, Enginuity, is one of 27 businesses receiving funding and mentorship through Innovacorp’s ocean technology and clean technology acceleration programs this fall.
Congratulations to all the Nova Scotia start-ups selected to participate in our 2017 ocean technology and clean technology acceleration initiatives.
Innovacorp announced the appointment of two new members to its board of directors today, Nov. 9.
The new appointments are David Wilson, president of Wilsons Security, and Dawn Umlah, chief operating officer of Spring Loaded Technology.
Appili Therapeutics Inc. (Appili), an anti-infective drug development company, announced today it has been awarded a $1.2 million USD grant by the Department of Defense, Congressionally Directed Medical Research Programs, Peer Reviewed Medical Research Program.
A new wearable technology company in Halifax is receiving $50,000 in funding and business guidance through Innovacorp’s Spark Innovation Challenge. The business, Axem Neurotechnology, is one of four winners selected in the Spark Halifax region of the province.